ICUCW
SeaStar Medical Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.02
−5.49%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$0.95
- Revenue estimate
- $500.0K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.91
- EPS estimate
- -$0.97
- Revenue actual
- $615.0K
- Revenue estimate
- $486.5K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +28.6%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.97 | -$0.91 | Beat 6.19% | $615.0K |
| May 13, 2026 | -$0.82 | -$0.90 | Miss -9.09% | $495.0K |
| Mar 25, 2026 | -$1.08 | -$0.80 | Beat 25.93% | $420.0K |
| Nov 13, 2025 | -$1.50 | -$0.13 | Beat 91.23% | $183.0K |
| Aug 13, 2025 | -$0.43 | -$0.18 | Beat 58.90% | $338.0K |
| May 14, 2025 | -$0.52 | -$0.00 | Beat 99.92% | $293.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026